Insider Buy/Sell Details for the Biotechnology Industry — May 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1133)
INSMED Inc (INSM)
Lewis William — Director
Shares
5,753
Price
$105.32
Total Value
$605.91K
Shares Held After
292,848
% of Holdings
1.9%
Rallybio Corp (RLYB)
ADAR1 Capital Management, LLC — 10% Owner
Shares
6,009
Price
$13.98
Total Value
$83.98K
Shares Held After
916,152
% of Holdings
0.7%
Shares
1,700,000
Price
$4.35
Total Value
$7.39M
Shares Held After
3,792,171
% of Holdings
31.0%
Adaptive Biotechnologies Corp (ADPT)
PISKEL KYLE — Chief Financial Officer
Shares
3,115
Price
$13.04
Total Value
$40.62K
Shares Held After
256,725
% of Holdings
1.2%
Liquidia Corp (LQDA)
JEFFS ROGER — Director
Shares
25,000
Price
$56.77
Total Value
$1.42M
Shares Held After
1,173,095
% of Holdings
2.1%
Werewolf Therapeutics, Inc. (HOWL)
EVNIN LUKE — Director
Shares
22,184
Price
$0.50
Total Value
$11.09K
Shares Held After
1,104,312
% of Holdings
2.0%
Atara Biotherapeutics, Inc. (ATRA)
Nguyen AnhCo — Director
Shares
5,241
Price
$9.13
Total Value
$47.84K
Shares Held After
137,837
% of Holdings
3.7%
Bicara Therapeutics Inc. (BCAX)
Mazumdar Claire — Director
Shares
2,978
Price
$20.35
Total Value
$60.60K
Shares Held After
362,152
% of Holdings
0.8%
Bicara Therapeutics Inc. (BCAX)
Mazumdar Claire — Director
Shares
12,022
Price
$19.96
Total Value
$239.98K
Shares Held After
365,130
% of Holdings
3.2%
Fortrea Holdings Inc. (FTRE)
Parks Robert — Chief Accounting Officer
Shares
2,000
Price
$13.44
Total Value
$26.88K
Shares Held After
20,389
% of Holdings
8.9%
Atara Biotherapeutics, Inc. (ATRA)
Grant-Huerta Yanina — Chief Accounting Officer
Shares
2,414
Price
$9.13
Total Value
$22.04K
Shares Held After
49,636
% of Holdings
4.6%
Pharvaris N.V. (PHVS)
Modig Berndt — Director
Shares
2,292
Price
$29.22
Total Value
$66.98K
Shares Held After
137,500
% of Holdings
1.6%
Ainos, Inc. (AIMD)
chiang yao-chung — Director
Shares
500
Price
$1.65
Total Value
$825.00
Shares Held After
1,329
% of Holdings
37.6%
Corvus Pharmaceuticals, Inc. (CRVS)
MILLER RICHARD A MD — Director
Shares
1,932
Price
$12.01
Total Value
$23.20K
Shares Held After
1,195,035
% of Holdings
0.2%
Corvus Pharmaceuticals, Inc. (CRVS)
MILLER RICHARD A MD — Director
Shares
5,000
Price
$12.05
Total Value
$60.25K
Shares Held After
1,193,103
% of Holdings
0.4%
Replimune Group, Inc. (REPL)
Hill Emily Luisa — Chief Financial Officer
Shares
7,812
Price
$5.08
Total Value
$39.68K
Shares Held After
236,556
% of Holdings
3.2%
Replimune Group, Inc. (REPL)
Sarchi Christopher — Chief Commercial Officer
Shares
8,626
Price
$5.08
Total Value
$43.82K
Shares Held After
192,962
% of Holdings
4.3%
Replimune Group, Inc. (REPL)
Schwendenman Andrew — Chief Accounting Officer
Shares
7,894
Price
$5.08
Total Value
$40.10K
Shares Held After
107,057
% of Holdings
6.9%
Lexeo Therapeutics, Inc. (LXEO)
Otero Jose Manuel — Chief Operating Officer
Shares
1,302
Price
$5.07
Total Value
$6.61K
Shares Held After
130,088
% of Holdings
1.0%
Replimune Group, Inc. (REPL)
Patel Sushil — Director
Shares
37,324
Price
$5.08
Total Value
$189.61K
Shares Held After
747,492
% of Holdings
4.8%
Replimune Group, Inc. (REPL)
Astley-Sparke Philip — Director
Shares
17,657
Price
$5.08
Total Value
$89.70K
Shares Held After
1,412,414
% of Holdings
1.2%
Replimune Group, Inc. (REPL)
Xynos Konstantinos — Chief Medical Officer
Shares
14,023
Price
$5.08
Total Value
$71.24K
Shares Held After
235,662
% of Holdings
5.6%
Enliven Therapeutics, Inc. (ELVN)
Collins Helen Louise — CHIEF MEDICAL OFFICER
Shares
223
Price
$41.21
Total Value
$9.19K
Shares Held After
25,000
% of Holdings
0.9%
Enliven Therapeutics, Inc. (ELVN)
Collins Helen Louise — CHIEF MEDICAL OFFICER
Shares
1,302
Price
$40.25
Total Value
$52.40K
Shares Held After
25,223
% of Holdings
4.9%
Enliven Therapeutics, Inc. (ELVN)
Collins Helen Louise — CHIEF MEDICAL OFFICER
Shares
3,475
Price
$39.53
Total Value
$137.38K
Shares Held After
26,525
% of Holdings
11.6%
Lexeo Therapeutics, Inc. (LXEO)
Townsend Richard Nolan — Director
Shares
3,342
Price
$5.06
Total Value
$16.93K
Shares Held After
336,764
% of Holdings
1.0%
GYRE THERAPEUTICS, INC. (GYRE)
Ye Weiguo — Chief Operating Officer
Shares
200
Price
$6.62
Total Value
$1.32K
Shares Held After
700,000
% of Holdings
0.0%
Kura Oncology, Inc. (KURA)
Bair Teresa Brophy — Chief Legal Officer
Shares
2,256
Price
$9.38
Total Value
$21.16K
Shares Held After
226,931
% of Holdings
1.0%
CNS Pharmaceuticals, Inc. (CNSP)
Charles Faith L. — Director
Shares
7,100
Price
$4.79
Total Value
$34.00K
Shares Held After
7,100
% of Holdings
100.0%
Orchestra BioMed Holdings, Inc. (OBIO)
Aryeh Jason — Director
Shares
665
Price
$3.75
Total Value
$2.49K
Shares Held After
118,118
% of Holdings
0.6%
BIOCRYST PHARMACEUTICALS INC (BCRX)
McKee Amy E — Director
Shares
11,180
Price
$8.97
Total Value
$100.28K
Shares Held After
31,252
% of Holdings
26.3%
Zai Lab Ltd (ZLAB)
Du Ying — Director
Shares
50,000
Price
$19.00
Total Value
$949.76K
Shares Held After
1,122,626
% of Holdings
4.3%
Mineralys Therapeutics, Inc. (MLYS)
Rodman David Malcom — Chief Medical Officer
Shares
417
Price
$27.55
Total Value
$11.49K
Shares Held After
63,443
% of Holdings
0.7%
Tenaya Therapeutics, Inc. (TNYA)
Higa Tomohiro — SVP, Finance
Shares
1,485
Price
$0.79
Total Value
$1.18K
Shares Held After
118,267
% of Holdings
1.2%
Tenaya Therapeutics, Inc. (TNYA)
Tingley Whittemore — Chief Medical Officer
Shares
3,121
Price
$0.79
Total Value
$2.48K
Shares Held After
215,497
% of Holdings
1.4%
EXELIXIS, INC. (EXEL)
Senner Christopher J. — EVP and CFO
Shares
34,901
Price
$50.00
Total Value
$1.75M
Shares Held After
952,317
% of Holdings
3.5%
EXELIXIS, INC. (EXEL)
Hefti Brenda — SVP and General Counsel
Shares
6,625
Price
$50.21
Total Value
$332.64K
Shares Held After
106,762
% of Holdings
5.8%
Tenaya Therapeutics, Inc. (TNYA)
Ali Faraz — Director
Shares
3,390
Price
$0.79
Total Value
$2.69K
Shares Held After
440,014
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
40
Price
$570.18
Total Value
$22.81K
Shares Held After
18,876
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,322
Price
$569.56
Total Value
$752.96K
Shares Held After
18,916
% of Holdings
6.5%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,304
Price
$568.43
Total Value
$741.23K
Shares Held After
20,238
% of Holdings
6.1%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
2,785
Price
$568.48
Total Value
$1.58M
Shares Held After
21,542
% of Holdings
11.4%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,796
Price
$566.39
Total Value
$1.02M
Shares Held After
24,327
% of Holdings
6.9%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
2,131
Price
$565.44
Total Value
$1.20M
Shares Held After
26,123
% of Holdings
7.5%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
422
Price
$564.30
Total Value
$238.14K
Shares Held After
28,254
% of Holdings
1.5%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
200
Price
$562.91
Total Value
$112.58K
Shares Held After
28,676
% of Holdings
0.7%
BridgeBio Pharma, Inc. (BBIO)
Trimarchi Thomas — President and CFO
Shares
3,195
Price
$65.95
Total Value
$210.71K
Shares Held After
359,194
% of Holdings
0.9%
BridgeBio Pharma, Inc. (BBIO)
Trimarchi Thomas — President and CFO
Shares
10,456
Price
$64.82
Total Value
$677.71K
Shares Held After
362,389
% of Holdings
2.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
280
Price
$569.99
Total Value
$159.60K
Shares Held After
40,513
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,077
Price
$569.42
Total Value
$613.26K
Shares Held After
40,793
% of Holdings
2.6%
Showing 151–200 of 1133 transactions (page 4 of 23)